Health News Releases

  • Today October 26
October 24, 15:50
AGC Biologics Partners with Rarity PBC to Advance Life-Saving Gene Therapy for “Bubble Baby Disease”
AGC Biologics, your friendly CDMO expert, today announced an agreement with Rarity PBC to provide comprehensive development and Good Manufacturing Practice (GMP) manufacturing for Rarity’s gene therap
October 23, 17:35
BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54341613&newsitemid=20251020512177&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5
October 23, 16:58
Galderma Delivers Record Net Sales of 3.737 Billion USD in the First Nine Months of 2025 and 15.0% Year-on-Year Growth at Constant Currency, Raises Full-Year Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the first nine months of 2025, delivering record net sales along with strong commerci
October 23, 15:00
Hologic to be Acquired by Blackstone and TPG for up to $79 per Share
Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds managed by Blackstone (“Blackstone”) and TPG in a transaction valued at up to $79 p
Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
October 23, 14:10
Wilmington PharmaTech Continues Expansion with Significant Investment from Curewell Capital
Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development, and manufacturing organization (CRDMO) focused on custom small molecule API development and manufacturing, today a
HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics
October 23, 11:40
HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members
HistoSonics (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhistosonics.com%2F&esheet=54343102&newsitemid=20251022130560&lan=en-US&anchor=HistoSonics&index=1&md5=40fd847d883559ad8d0
Rigaku Technology Taiwan Co., Ltd., located in Tai Yuen Hi-Tech Industry Park
October 22, 17:15
Rigaku opens Rigaku Technology Center Taiwan
Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) hereby announces the establishment of Rigaku Technology Taiwan Co., Ltd. (hereinafter “RTTW”), a ne
Ferrer’s pharmaceutical production plant in Sant Cugat del Valles, Barcelona, Spain.
October 22, 15:55
Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule
Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical trial designed to assess the efficacy, safety, and ph
Baszucki Group 2025 Metabolic Psychiatry Scholar Award Recipients
October 22, 15:15
Baszucki Group Announces Six Recipients of the Metabolic Psychiatry Scholar Award for Emerging Scientific Leaders Advancing Mental Health Innovation
Baszucki Group is proud to announce the six recipients of the first-ever Metabolic Psychiatry Scholar Award (https://baszuckigroup.com/metabolic-psychiatry-scholar-award/), a new initiative that suppo
October 22, 14:50
Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2F&esheet=54343084&newsitemid=20251021006409&lan=en-US&anchor=TSE%3A4502%2FNYSE%
Photo credit: IFF
October 22, 11:10
IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation
IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic collaboration with BASF, one of the world’s largest chemical companies and le
Kyung-Ah Kim, President & CEO of Samsung Bioepis (left) and Zhaoyuan ‘Tony’ Chen, Founder and CEO of
October 21, 09:45
Samsung Bioepis And Phrontline Announce a Global Strategic Partnership to Advance Best-in-Class Antibody-Drug Conjugate Therapeutics for Solid Tumors
Samsung Bioepis Co., Ltd. and Phrontline Biopharma, a clinical-stage biotechnology company advancing a new generation of Antibody-Drug Conjugates (ADCs), today announced that the companies have entere
October 20, 15:07
Iksuda Presents Encouraging IKS014 Phase 1 Data at ESMO
Iksuda Therapeutics (Iksuda), the developer of class leading, antibody drug conjugates (ADCs), today announces the presentation of new data from its Phase 1 study of IKS014, a human epidermal growth f
October 19, 16:02
Pimicotinib Treatment Demonstrates Deep and Durable Tumor Responses and Continued Improvements in Pain and Function for Patients with TGCT
Merck, a leading science and technology company, today announced the presentation of longer-term results from the global Phase 3 MANEUVER trial evaluating pimicotinib, an investigational colony stimul
HistoSonics Announces Oversubscribed $250 Million Growth Financing
October 17, 14:50
HistoSonics Announces Oversubscribed $250 Million Growth Financing
HistoSonics, Inc., the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the closing of an oversubscribed $250 million financing led by its new owners
Credits to Roquette
October 17, 14:15
New Roquette Pharmaceutical Innovation Center to Strengthen Latin America as Collaborative Hub
Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for health, nutrition and bio industrial markets, today, celebrates the grand opening of its dedicated Health & Pharm
October 16, 16:15
SS&C Technologies Completes Acquisition of Calastone
SS&C Technologies Holdings, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.ssctech.com%2F%3Futm_campaign%3DSSC2025-Enterprise-Press-Release-1025%26utm_medium%3Dpressreleas
October 15, 11:45
BeOne Medicines’ Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fbeonemedicines.com%2F&esheet=54337814&newsitemid=20251013125479&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md5
October 14, 11:40
Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54336442&newsitemid=20251009983648&lan=en-US&anchor=Parse+Biosciences&index=1&md
Pictured (L-R): Heidi co-founders Waleed Mussa, CFO; Dr. Thomas Kelly, CEO; and Yu Liu, CTO.
October 12, 13:00
Heidi Secures $65 Million USD in Series B Funding to Accelerate Building an AI Care Partner for Every Clinician
Heidi (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.heidihealth.com%2F&esheet=54334156&newsitemid=20251005012225&lan=en-US&anchor=Heidi&index=1&md5=660ced366440a0565290ef7747c
October 12, 11:00
Mundipharma announces patient enrolment completion in Phase III ReSPECT clinical trial for REZZAYO® (rezafungin)
Mundipharma today announced completion of patient enrolment for the ongoing, global Phase III ReSPECT trial evaluating REZZAYO® (rezafungin). The ReSPECT trial is a global, randomised, double-blind
A pharmacist advises a consumer on the purchase of Haleon’s Otrivin nasal mist.
October 12, 10:30
Haleon Selects Salesforce Agentforce Life Sciences Cloud for Customer Engagement to Improve Engagement with Pharmacies and Healthcare Professionals with AI
Haleon plc (LSE/NYSE:HLN), a leading global consumer company that specialises in everyday health and Salesforce (NYSE:CRM), the world’s #1 AI CRM, today announced that Haleon will leverage Salesforce
October 10, 17:20
Bimiralisib, Topical PI3K/mTOR Inhibitor Shows Up To 92% Clearance Rate And Superior Tolerability In Proof-Of-Concept Actinic Keratosis Study
Torqur AG, subsidiary of Swiss Rockets incubator and a clinical-stage company advancing targeted therapies in oncodermatology and oncology, announced the results of the full Phase 2 proof-of-concept s
October 10, 16:55
Tempus Joins Parse Biosciences’ Certified Service Provider Network
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54333556&newsitemid=20251008146500&lan=en-US&anchor=Parse+Biosciences&index=1&md5
Masimo SET® Pulse Oximetry and RD SET® Sensors
October 10, 14:40
In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones
Masimo (https://www.masimo.com/) (NASDAQ: MASI) today announced the findings of an exploratory analysis for a unique feasibility study published in CHEST Critical Care in which Dr. Andrew Goodwin and
October 10, 11:10
TCG Crossover (“TCGX”) Announces Oversubscribed $1.3B TCGX Fund III
TCG Crossover (“TCGX”) today announced the successful closing of its third fund, TCGX Fund III, with $1.3 billion in capital commitments. Fund III attracted support from both current TCGX investors an
October 05, 11:55
Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments
Kinaxis® (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.kinaxis.com%2Fen&esheet=54333058&newsitemid=20251002088321&lan=en-US&anchor=Kinaxis%26%23174%3B&index=1&md5=bc238f272987
October 05, 11:40
Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair
Neuraptive Therapeutics, Inc., a biotechnology company focused on developing novel therapies to improve outcomes in peripheral nerve injuries (PNI), today announced the first patient has been enrolled
WHOOP Launches Clinician-Reviewed Advanced Labs, Unlocking a Comprehensive View of Human Health
October 02, 14:50
WHOOP Launches Clinician-Reviewed Advanced Labs, Unlocking a Comprehensive View of Human Health
WHOOP (https://www.whoop.com/kr/en/), the human performance company, today announced the launch of WHOOP Advanced Labs (https://www.whoop.com/kr/en/advanced-labs/), a groundbreaking new feature that c
October 02, 14:50
Dentalis Earns 5 VOHC® Seals, Positioning for Global Expansion in Animal Health
Dentalis Animal Health Inc. is proud to announce a landmark achievement in veterinary dentistry: the company has been awarded five prestigious Veterinary Oral Health Council (VOHC®) Seals of Approval,
October 02, 11:10
Parse Biosciences Expands Global Access by Certifying Single Cell Discoveries as a Service Provider
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54330033&newsitemid=20250930263922&lan=en-US&anchor=Parse+Biosciences&index=1&md5
October 01, 15:35
Microplastics in the Air: Global Study Uncovers Concerning Levels of Daily Exposure
The PlasticDustCloud project, a global study led by the Eurofins Environment Testing network, has revealed alarming microplastic pollution in air, with deposition rates of up to 1,300 microplastics pe
September 24, 16:10
AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education
Galderma will present six posters with the latest updates from its science-backed aesthetic portfolio at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Dubai, United Arab Emirates, from
September 24, 15:30
Variational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery
Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply Variational AI’s Enki™ platform
September 24, 09:32
20,000 + Takeda Employees Voted to Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems in 94 Countries
Takeda (TOKYO:4502/NYSE: TAK) today committed JPY 4.6 billion (approx. USD 32.1 million) to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment t
September 18, 14:40
Rubedo Life Sciences Announces U.S. FDA Clearance of IND for Selective GPX4 Modulating Lead Drug Candidate RLS-1496 for Actinic Keratosis, Expands Clinical Advisory Board
Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing selective cellular rejuvenation medicines targeting aging cells, today announced
Continuous Patient Monitoring with Masimo SET® Pulse Oximetry and Patient SafetyNet™
September 18, 14:25
New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs
Masimo (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.masimo.com&esheet=54324636&newsitemid=20250917266545&lan=en-US&anchor=Masimo&index=1&md5=1c2d4fc2fd80ea476e53a7e74df69244)
September 18, 13:55
Merck to Present New Data Highlighting Durable Effects of MAVENCLAD® in Relapsing Multiple Sclerosis (RMS) at ECTRIMS 2025
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the presentation of over 30 abstracts from its multiple sclerosis (MS) portfolio. Ne
September 17, 16:10
Galderma’s Groundbreaking Real-World Study Reveals the Biological Toll of Modern Living and Urban Environments on Sensitive Skin
Galderma today announced new data from a first-of-its-kind real-world clinical study conducted in China assessing the biological impact of different lifestyles and their associated environmental facto
Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single
September 17, 10:05
Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technolo
September 17, 08:59
Takeda and VELA to Ship Medicines Across the Atlantic Using First-of-its-Kind Wind-Powered Trimaran
Takeda (TSE:4502/NYSE:TAK) and VELA Transport today announced their business partnership, with Takeda set to become the first biopharmaceutical company to transport its products between Europe and the
September 16, 17:35
FrieslandCampina Ingredients Expands R&D Capabilities with New State-of-the-Art Application Centre in Singapore
FrieslandCampina Ingredients, a global leader in proteins and prebiotics, has announced the opening of a new application centre in Singapore, representing a 30% increase of R&D space in the city-state
Group photo of representatives from MEDIPEAU Inc. and GNPharm at the conference venue
September 16, 14:00
MEDIPEAU Showcases its Film-Type Wound Dressing Cream at 51st Annual Fall Meeting of Korean Pediatric Association
MEDIPEAU Inc., a company specializing in therapeutic solutions for atopic dermatitis, introduced its groundbreaking “BARRICURE Aid Film MD” during the 51st Annual Fall Meeting of the Korean Pediatric
September 16, 09:45
Helmholtz Munich and Parse Biosciences GigaLab Generate World’s Largest Human Lung Tissue Perturbation Atlas
Helmholtz Munich and Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com%2F&esheet=54323217&newsitemid=20250915189668&lan=en-US&anchor=Parse+Bi
RPTs: Pre-clinical Drug Discovery Pipeline
September 12, 16:20
Medicines Discovery Catapult and Crown Bioscience Form Strategic Global Alliance for Radiopharmaceutical Innovation
Medicines Discovery Catapult (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fmd.catapult.org.uk%2F&esheet=54321838&newsitemid=20250911458780&lan=en-US&anchor=Medicines+Discovery+Cat
September 12, 15:20
Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec
Ferring Pharmaceuticals Co., Ltd. announced that the PMDA has accepted the NDA for nadofaragene firadenovec for review, following submission on August 27th, 2025. This non-replicating gene therapy, ad
Aster Guardians Global Nursing Award worth USD 250,000 (Photo: AETOSWire)
September 12, 13:35
Nominations Open for Fifth Edition of Aster Guardians Global Nursing Award 2026 Worth USD 250,000
Aster DM Healthcare has announced the launch of the fifth edition of the Aster Guardians Global Nursing Award, one of the world’s most prominent recognition for nursing excellence worth USD 250,000.
September 12, 10:55
Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase
Promega Corporation (https://www.promega.kr/?utm_source=businesswire.com&utm_medium=referral&utm_campaign=%28referral%29) has entered a strategic partnership with Watchmaker Genomics (https://www.watc
September 11, 15:50
EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch
Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking pla
September 10, 16:30
Galderma Launches Alastin® in China, Supporting the Skin’s Natural Regenerative Abilities in a Rapidly Expanding Market
Galderma (SIX: GALD) today announced the launch of four core Alastin® products in China, marking the premium medical skincare brand’s debut in one of the world’s fastest growing aesthetic skincare mar
25 per page50 per page75 per page100 per page